The Puget Sound-area drug chain said Tuesday that veteran business executives Kathy Gersch, Mark Schwartz and Kristi Marchbanks have joined the Bartell Drugs board, bringing range of strategic, entrepreneurial and cross-industry experience to the company.
“We are delighted to add these three very talented outside directors to our board,” Jean Bartell Barber, vice chairman and treasurer of Bartell Drugs, said in a statement. “I anticipate that they will provide significant strategic guidance to our company.”
Gersch, executive vice president and chief marketing officer at consultancy Kotter International, has helped companies lead transformation efforts globally in a breadth of sectors — including health care, consumer products, retail, manufacturing, energy, financial services and aerospace — through Kotter and as an independent consultant.
Her retail background includes serving as vice president, chief marketing officer and general manager of Drugstore.com, leading its over-the-counter business and Beauty.com business units; vice president of finance, strategic planning and administration at Nordstrom Product Group; and vice president at Faҫonnable International.
With more than 20 years of experience as a chief executive officer, chief financial officer and board member, including with such notable companies as Starbucks, investor Schwartz advises the CEOs of 18 portfolio companies in the food (retailing, consumer packaged goods and agri-tech), technology (software, digital media and e-commerce), health care (medical devices and biopharma) and manufacturing industries.
He serves on several corporate boards, including Glass Media, and co-founded Hispanic grocery retailer Bodega Latina Corp. (El Super), which operates stores in California, Nevada, Arizona, New Mexico and Texas.
Bartell Drugs noted that Marchbanks is an experienced board member and corporate strategy executive “with demonstrated ability to get results that create shareholder value.”
Working in startup and Fortune 500 environments — including Amazon, Corbis and SeaBright Holdings — Marchbanks has built new companies, launched products and scaled existing businesses by accelerating revenue growth, according to Bartell Drugs.
The drug chain said she has proven results in multiple industries and was early to see the strategic value in new technologies and industries, such as big data, cloud computing and software-as-a-service (SaaS).
Her board service has included the University of Washington’s Buerk Center for Innovation and Entrepreneurship, Smith Brothers Farms and Harvard Business School of Puget Sound, among other organizations.
Besides Bartell Barber and chairman George Bartell, other directors on Bartell Drugs’ eight-member board include Shelley Milano, general counsel at retailer L Brands; Bill Brakken, former CFO of Lanoga Corp.; and Frank Segrave, formerly senior vice president at Cardinal Health Inc. and vice president of pharmacy at Walmart and currently founder and CEO of Silvergate Pharmaceuticals.
Overall, Bartell Drugs operates 65 stores in Washington’s King, Snohomish and Pierce counties. Plans call for its 66th and 67th stores to open later this summer and its 68th store to open in the early part of next year.